<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Microbiology and pathogenesis of Klebsiella pneumoniae infection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Microbiology and pathogenesis of Klebsiella pneumoniae infection</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Microbiology and pathogenesis of Klebsiella pneumoniae infection</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wen-Liang Yu, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 21, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Klebsiella pneumoniae</em> is a gram-negative, lactose-fermenting, non-motile, aerobic rod-shaped bacterium. It has been a known human pathogen since it was first isolated in the late nineteenth century by Edwin Klebs.</p><p>The microbiology, pathogenesis, and epidemiology of infections due to <em>K. pneumoniae</em> will be reviewed here. The epidemiology, clinical manifestations, diagnosis, and treatment of infections due to this organism are discussed separately. (See  <a class="medical medical_review" href="/d/html/3122.html" rel="external">"Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>K. pneumoniae</em> has three subspecies with homologous DNAs but different biochemical reactions: <em>K. pneumoniae</em> subsp <em>pneumoniae</em>, <em>K. pneumoniae</em> subsp <em>ozaenae</em>, and <em>K. pneumoniae</em> subsp <em>rhinoscleromatis</em>. For the remainder of this topic review, <em>K. pneumoniae</em> will specifically refer to <em>K. pneumoniae</em> subsp <em>pneumoniae</em>.</p><p>The following are the characteristic biochemical reactions of the different organisms:</p><p class="bulletIndent1"><span class="glyph">●</span><em>K. pneumoniae</em> is lactose fermenting, H2S- and indole-negative, has a positive Voges-Proskauer (VP) reaction, is capable of growth in KCN and using citrate as a sole carbon source, and is incapable of growth at 10ºC.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The other two subspecies (<em>ozaenae</em> and <em>rhinoscleromatis</em>) are indole-negative with a negative VP reaction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Klebsiella oxytoca</em>, which is one of the other species of the genus, is indole-positive, has a positive VP reaction, and is able to grow at 10ºC.</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Five major virulence factors of <em>K. pneumoniae</em> are known to contribute to the pathogenesis of infection: capsular serotype, hypermucoviscosity phenotype, lipopolysaccharide, siderophores, and pili (<a class="graphic graphic_table graphicRef79361" href="/d/graphic/79361.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. The degree of virulence conferred by <em>K. pneumoniae</em> can be determined by several methods (<a class="graphic graphic_table graphicRef68146" href="/d/graphic/68146.html" rel="external">table 2</a>). A single strain of <em>K. pneumoniae</em> can express an inconsistent degree of virulence in different virulence testing assays.</p><p>Hypervirulent <em>K. pneumoniae</em> (hvKp) has been defined as hypermucoviscous and aerobactin-positive by some experts [<a href="#rid2">2,3</a>]. </p><p class="headingAnchor" id="H4"><span class="h2">Capsular serotypes</span><span class="headingEndMark"> — </span>The capsular polysaccharide antigens of <em>K. pneumoniae</em> can be classified into 77 serotypes. Serotype prevalence varies widely in different regions [<a href="#rid4">4-11</a>]. Worldwide, K2 is the most common capsular serotype of human clinical isolates, usually from urine or sputum specimens [<a href="#rid4">4</a>]. However, in different series, serotypes 2, 21, and 55 were most common in Europe [<a href="#rid4">4</a>], and 21, 2, and 55 were most common in North America [<a href="#rid4">4</a>]; K1 was the predominant capsular serotype in bacteremia, liver abscess, and septic endophthalmitis isolates in Taiwan [<a href="#rid5">5-8</a>] and in liver abscess isolates in Korea [<a href="#rid9">9</a>]; and K54 was the major serotype from urinary, sputum, and blood isolates in Australia [<a href="#rid10">10</a>].</p><p>The K1 and K2 isolates are generally more virulent than non-K1/K2 isolates in terms of lethality for a mouse when injected intraperitoneally [<a href="#rid12">12</a>]. The discrepancies in the degree of virulence observed among strains with different capsule types may be explained by two major mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span>Macrophages with the lectin or mannose receptor can recognize the capsular sugar sequences of mannose-alpha-2/3-mannose or L-rhamnose-alpha-2/3-L-rhamnose, particular of non-K1/K2 antigens. Subsequent macrophage-mediated ingestion and killing of organisms is nonopsonic and known as lectinophagocytosis [<a href="#rid13">13,14</a>]. The K1 or K2 antigens lack these mannose or rhamnose sequences, which can protect these isolates from lectinophagocytosis [<a href="#rid15">15,16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Strains of <em>K. pneumoniae</em> with K1 or K2 capsule serotypes are more often hypermucoviscous than non-K1/K2 strains [<a href="#rid7">7</a>]. (See <a class="local">'RmpA gene'</a> below.)</p><p></p><p>Some capsular serotypes such as K1, K2, and K25 may contribute to host infection by protecting the organism against phagocytosis by neutrophils [<a href="#rid16">16,17</a>]. In addition, the capsular polysaccharide may play an important role in the development of respiratory tract infection by protecting against phagocytosis by alveolar macrophages [<a href="#rid18">18</a>]. </p><p class="headingAnchor" id="H5"><span class="h2">Hypermucoviscosity phenotype</span><span class="headingEndMark"> — </span><em>K. pneumoniae</em> strains possess the hypermucoviscosity phenotype if they are capable of producing a mucoviscous exopolysaccharide web. In the microbiology laboratory, these strains grow in sticky colonies on agar plates and are identified by a string test [<a href="#rid19">19</a>]. A positive string test is indicated by a &gt;5 mm viscous string from the colony on an agar plate when stretched by a standard bacteriologic loop (<a class="graphic graphic_picture graphicRef53292" href="/d/graphic/53292.html" rel="external">picture 1</a>) [<a href="#rid20">20</a>]. The clinically invasive nature of some <em>K. pneumoniae</em> strains correlates with these microbiologic characteristics.</p><p>Strains with the hypermucoviscosity phenotype or with enhanced production of polysaccharide capsule independent of capsular K serotypes are more resistant to complement-mediated serum killing than those without the hypermucoviscosity phenotype or those with reduced capsule production [<a href="#rid20">20,21</a>]. The clinical importance of these observations was illustrated in a study in which hypermucoviscosity correlated with high serum resistance and was present in 52 of 53 strains causing invasive infection (liver abscess) compared with 9 of 52 noninvasive strains [<a href="#rid20">20</a>].</p><p>A number of clinical studies have demonstrated a significant association between the hypermucoviscosity phenotype and a destructive tissue abscess syndrome, including abscesses in the liver and/or other sites [<a href="#rid7">7,22-26</a>].</p><p>These relationships were illustrated in a review of 151 <em>K. pneumoniae</em> isolates from patients with bacteremia [<a href="#rid22">22</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The hypermucoviscosity phenotype was found in 38 percent. The rate was higher with community-acquired compared with nosocomial infections (49 versus 15 percent), a finding that is consistent with the association of the tissue abscess syndrome with community-acquired infections. (See <a class="local">'Association with primary liver abscess'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among 95 isolates from secondary bacteremia (excluding five isolates from mixed infections), a hypermucoviscosity phenotype was found in a significantly higher proportion of isolates from any abscess site (eg, liver, neck) compared with nonabscess sites such as the urinary tract or to isolates from primary bacteremia (85 versus 23 and 25 percent).</p><p></p><p>The outer layer of the capsule of most <em>K. pneumoniae</em> consists of a network structure of fine fibers derived from capsular polysaccharide [<a href="#rid27">27</a>], known as the exopolysaccharide web. This structure is encoded by the capsular polysaccharide (cps) gene cluster on the chromosome [<a href="#rid28">28</a>] and is positively regulated by plasmid-mediated genes, including rmpA (regulator of mucoid phenotype gene A) [<a href="#rid28">28-30</a>], rmpA2 [<a href="#rid31">31,32</a>] and magA (mucoid associated gene A) [<a href="#rid20">20</a>].</p><p>A study in the United States reported that mucoviscous-mediated anti-phagocytosis is a primary determinant of pulmonary clearance of clinical respiratory<em> K. pneumoniae</em> isolates [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H6"><span class="h3">RmpA gene</span><span class="headingEndMark"> — </span>The capsule of <em>K. pneumoniae</em> is encoded by the capsular polysaccharide (cps) gene cluster [<a href="#rid28">28</a>], which may be regulated by plasmid-born rmpA and rmpA2 genes to enhance extracapsular polysaccharide synthesis and produce the hypermucoviscosity phenotype [<a href="#rid28">28-32</a>].</p><p>The rmpA gene was significantly associated with a hypermucoviscosity phenotype, being found in 90 percent of such isolates compared with 22 percent of isolates without a hypermucoviscosity phenotype. On the other hand, the hypermucoviscosity phenotype occurred in only 81 percent of rmpA-positive isolates. These observations suggest that other factors control full expression of rmpA or the hypermucoviscosity phenotype [<a href="#rid22">22</a>]. Non-rmpA factors that might contribute to the hypermucoviscosity phenotype include rmpA2 (as in some rmpA-negative/rmpA2-positive strains), aerobactin iron uptake chelate (Iuc) system, and the transcriptional regulators KvrA and KvrB [<a href="#rid34">34</a>].</p><p>Mutation of rmpA gene (insertion or deletion), however, may contribute to the negative hypermucoviscosity phenotype and low virulence in some rmpA-positive isolates [<a href="#rid35">35</a>]. </p><p class="headingAnchor" id="H7"><span class="h3">MagA gene</span><span class="headingEndMark"> — </span>MagA encodes a 43 kD outer membrane protein. The magA gene is located within an operon that is specific to the serotype K1 capsular polysaccharide (cps) gene cluster [<a href="#rid36">36-38</a>], and the operon containing magA is responsible for the K1 capsular serotype [<a href="#rid39">39</a>]. In one report, for example, serotype K1 was present in all 36 magA-positive strains compared to none of 38 magA-negative strains [<a href="#rid39">39</a>]. Restriction of magA to serotype K1 strains has also been noted in other studies [<a href="#rid7">7,40,41</a>]. Further sequencing of the magA<em> </em>flanking region revealed that magA<em> </em>was the serotype K1 allele of the polymerase wzy<em> </em>loci in the cps<em> </em>operon [<a href="#rid8">8,42,43</a>]. As magA was a K1-antigen–specific polymerase, it has been proposed that magA<em> </em>has to be renamed wzy<sub>KpK1</sub>, the capsular polymerase specific to <em>K. pneumoniae</em> serotype K1 [<a href="#rid43">43</a>]. Other serotypes K2, K5, K20, K54, K57 and a new capsular type KN1 have different alleles at the wzy loci, which are the capsular polymerases specific to their cps gene clusters of different serotypes [<a href="#rid8">8,44,45</a>]. </p><p>A study using transposon mutagenesis to identify candidate virulence genes demonstrated that magA-positive strains had a mucoviscous exopolysaccharide web, resisted phagocytosis, and produced liver abscesses and meningitis in mice [<a href="#rid20">20</a>]. On the other hand, magA-negative mutants of serotype K1 strains lacked the exopolysaccharide web, became susceptible to phagocytosis, and were not virulent.</p><p class="headingAnchor" id="H8"><span class="h3">Relationship between magA and rmpA</span><span class="headingEndMark"> — </span>Several studies have evaluated the relationship among magA, rmpA, and the hypermucoviscosity phenotype:</p><p class="bulletIndent1"><span class="glyph">●</span>The hypermucoviscosity phenotype is not confined to magA-positive isolates (ie, serotype K1 strains) [<a href="#rid22">22,41</a>] nor is it found in all magA-positive isolates [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RmpA can be responsible for the hypermucoviscosity phenotype of magA-negative isolates (such as K2 or other non-K1 serotype strains) [<a href="#rid22">22</a>], and rmpA-negative isolates of magA-positive strains may lack the hypermucoviscosity phenotype [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The k2A gene is seen only in serotype K2 strains and corresponds to the magA region in the cps gene cluster in serotype K1 isolates [<a href="#rid40">40</a>]. Thus, k2A in serotype K2 isolates may play a similar pathogenetic role as magA in serotype K1 isolates.</p><p></p><p>A report of 73 <em>K. pneumoniae</em> isolates from liver abscess evaluated the relationship between rmpA carriage and capsule serotype [<a href="#rid7">7</a>]. RmpA carriage was found in all 49 K1 or K2 isolates compared to 16 of 24 non-K1/K2 isolates, suggesting that K1/K2 isolates are generally more hypermucoviscous than non-K1/K2 isolates. In addition, K1/K2 isolates had more resistance to phagocytosis than rmpA-positive non-K1/K2 isolates. The latter observation is consistent with other studies showing that the mucoid phenotype mediated by the plasmid-encoded rmpA gene is an important virulence factor in addition to the capsule in K1 and K2 <em>K. pneumoniae</em> isolates [<a href="#rid30">30</a>].</p><p>In summary, the rmpA gene is a positive regulator of extracapsular polysaccharide synthesis and confers a hypermucoviscosity phenotype in most isolates. In K1 isolates, the magA gene is essential for the formation of the exopolysaccharide web, a process that can be enhanced by rmpA. Capsular serotypes K1 and K2 also may contribute to virulence, independent of rmpA and magA.</p><p class="headingAnchor" id="H9"><span class="h3">Association with primary liver abscess</span><span class="headingEndMark"> — </span>Primary liver abscess refers to infections that occur in the absence of a history of hepatobiliary disease. Most cases of <em>K. pneumoniae</em> primary liver abscess have been reported in Taiwan and are community-acquired [<a href="#rid6">6-8,20,22,23,39,46-52</a>].</p><p>MagA-positivity has been strongly associated with primary community-acquired liver abscess in humans and is less often present in other <em>K. pneumoniae</em> infections [<a href="#rid20">20,39</a>]. The association with magA was illustrated in a report in which 35 of 42 (83 percent) <em>K. pneumoniae</em> strains from patients with primary liver abscess were magA-positive compared with only 1 of 32 strains associated with other types of infection [<a href="#rid39">39</a>]. Similar findings were noted in another study in which magA was significantly more prevalent in invasive strains that caused primary liver abscess compared with noninvasive strains that did not (98 versus 28 percent) [<a href="#rid20">20</a>].</p><p>However, lower rates of magA (K1 capsular serotype)-positivity have been noted in other series of patients with liver abscess, with values ranging from 34 to 63 percent [<a href="#rid6">6,8,9,22,23,40</a>], and rmpA-positive isolates have predominated in several series [<a href="#rid7">7,8,22</a>]. The discrepancy in findings may be in part related to inconsistent distinction between primary and secondary liver abscess. As an example, a liver abscess in a patient with a small silent gallstone is more likely to represent a primary infection.</p><p>MagA and the hypermucoviscosity phenotype are much less common in <em>K. pneumoniae</em> secondary liver abscess as illustrated by the following observations:</p><p class="bulletIndent1"><span class="glyph">●</span>In a review of 129 patients with liver abscess in which 53 were considered primary and 76 were secondary [<a href="#rid8">8</a>]. The rate of K1 positivity was much higher in the primary abscesses (81 versus 42 percent). As noted above, magA is associated with the K1 capsular serotype [<a href="#rid36">36-39</a>]. Thus, prior studies showing an association between K1 and liver abscess, particularly if complicated by endophthalmitis, may have reflected magA-positive strains.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In two series, the hypermucoviscosity phenotype was present in 40 of 51 cases of primary liver abscess compared with 9 of 39 cases of cholangitis (78 versus 23 percent) [<a href="#rid22">22,23</a>].</p><p></p><p>Some studies have suggested that the K1 or K2 capsular serotype is a more important virulence determinant for <em>K. pneumoniae</em> liver abscess than magA or rmpA [<a href="#rid7">7</a>] and that genotype K1 may be particularly associated with the risk of metastatic infection [<a href="#rid8">8</a>]. Such infections can occur in patients without any underlying predisposing medical conditions, which is a reflection of the virulent nature of the K1 strains [<a href="#rid8">8</a>]. In addition, serum resistance assays have shown that K1 isolates were significantly more virulent than K2 or other isolates [<a href="#rid8">8</a>]. Non-K1 or K2 capsular types of <em>K. pneumoniae</em> strains causing primary liver abscess have mainly included K5, K20, K54, K57, and KN1 isolates, which were almost all rmpA-positive and of hypermucoviscosity phenotype [<a href="#rid8">8,44,45,53</a>].</p><p>A possible mechanism for the role of the K1 capsular serotype in virulence is that chromosomal regions with additional virulence genes (magA, kfu/PTS [a regulator of iron uptake], and allS) are selectively present on the serotype K1 genome; genotype K1 strains with all three genomic regions are strongly associated with primary liver abscess and metastatic infection [<a href="#rid52">52</a>]. A high prevalence of the plasmid-borne rmpA gene also may contribute to the virulence of K1 strains [<a href="#rid7">7,8</a>]. Another study in Taiwan also determined the prevalence of these virulence factors among 50 <em>K. pneumoniae</em> isolates causing primary liver abscesses. In general, the prevalence of hypermucoviscosity phenotype, plasmid-born rmpA, aerobactin, kfu, and allS genes is higher in K1 isolates than K2 and other non-K1/K2 isolates [<a href="#rid53">53</a>]. </p><p>Both the K1 capsular serotype and the hypermucoviscosity phenotype are associated with community-acquired rather than nosocomial <em>K. pneumoniae</em> infection, which could explain why isolates from primary liver abscess are almost exclusively acquired in the community [<a href="#rid22">22,47</a>].</p><p>A study in China reported that abundant capsule production is the cornerstone of hypervirulence, regardless of exopolysaccharides, in comparison between<em> K. pneumoniae</em> liver abscess strains and nonliver abscess strains [<a href="#rid54">54</a>].</p><p>Diabetes mellitus is a common risk factor for primary <em>K. pneumoniae</em> liver abscess [<a href="#rid6">6,9,48-50</a>] being present in 78 percent of 134 patients in one report [<a href="#rid6">6</a>]. The data are conflicting as to whether diabetes is [<a href="#rid6">6,48,50</a>] or is not [<a href="#rid8">8</a>] an independent risk factor for metastatic infection. The high prevalence of diabetes or impaired fasting glucose with <em>K. pneumoniae</em> liver abscess is not seen with other causes of liver abscess (eg, 75 versus 5 percent with polymicrobial liver abscess, and 70 versus 33 percent with non-<em>K. pneumoniae</em> liver abscess in two large series) [<a href="#rid48">48,49</a>].</p><p>Poor glycemic control reversibly impairs phagocytosis of K1 and K2 strains of <em>K. pneumoniae</em> but not other strains [<a href="#rid55">55</a>]. However, in the series of 177 cases of <em>K. pneumoniae</em> pyogenic liver abscess cited above, diabetes was significantly less common in K1 compared with non-K1 strains (54 versus 70 percent) and the median level of hemoglobin A1c was significantly lower in patients infected with K1 strains, indicating better glycemic control [<a href="#rid8">8</a>]. Similarly, the prevalence of diabetes mellitus was lower in patients with K1/K2 primary liver abscess than with non-K1/K2 liver abscess (53 versus 86 percent) [<a href="#rid56">56</a>]. K1/K2 isolates are virulent strains capable of causing illness among diabetic and non-diabetic hosts. These observations suggest that optimized glucose control may not be sufficient for reducing the risk of K1/K2 liver abscess in diabetic patients, but may be helpful in reducing non-K1/K2 liver abscess, which accounted for 12 (39 percent) of 31 cases of primary liver abscess in diabetic patients [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Lipopolysaccharide</span><span class="headingEndMark"> — </span><em>K. pneumoniae</em> serum resistance is mainly conferred by the lipopolysaccharide O side chain, which can impede C1q or C3b from binding to the bacterial cell membrane, thereby protecting the organism from subsequent complement-mediated membrane damage and cell death [<a href="#rid57">57-60</a>]. This effect has been demonstrated in mutant strains in which lack of the lipopolysaccharide O side chain is associated with sensitivity to complement-mediating killing [<a href="#rid57">57,58</a>]. The capsule in these strains played no role in serum resistance. However, some clinical <em>K. pneumoniae</em> isolates that lack the lipopolysaccharide O side chain retain resistance to complement-mediating killing if they are heavily encapsulated [<a href="#rid21">21</a>]. (See <a class="local">'Hypermucoviscosity phenotype'</a> above.)</p><p><em>Klebsiella</em> lipopolysaccharide may also contribute to virulence by other mechanisms. These include increasing lethality in pulmonary infection by enhancing the propensity for bacteremia [<a href="#rid61">61</a>], and acting as an endotoxin, by triggering cytokine pathways leading to the sepsis syndrome and septic shock. (See  <a class="medical medical_review" href="/d/html/1597.html" rel="external">"Pathophysiology of sepsis"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Siderophores</span><span class="headingEndMark"> — </span>Iron is an essential factor in the growth of Enterobacteriaceae such as <em>Klebsiella</em> [<a href="#rid62">62</a>]. Because of the scarcity of iron in the microenvironment, <em>K. pneumoniae</em> and other bacteria have developed multiple mechanisms to enhance iron uptake. These include synthesis of iron chelators (siderophores), such as enterobactin (also called enterochelin) and aerobactin [<a href="#rid62">62-64</a>], the aerobactin receptor to introduce exogenous aerobactin [<a href="#rid65">65</a>], and the kfu iron uptake system [<a href="#rid52">52</a>].</p><p>Enterobactin is the main iron uptake system and is synthesized by almost all <em>K. pneumoniae</em> strains [<a href="#rid66">66-68</a>]. In contrast, aerobactin synthesis has been infrequently found (less than 10 percent of strains) in most reports [<a href="#rid66">66-69</a>]. In a study of nine <em>K. pneumoniae</em> isolates with capsular serotype K1 or K2, all produced enterobactin, but only those that produced aerobactin were virulent, defined as an LD50 of less than 10(3) microorganisms [<a href="#rid64">64</a>]. Furthermore, transfer of the aerobactin gene into an avirulent strain enhanced virulence by 100-fold.</p><p>Both the aerobactin (<em>iuc</em> gene) and rmpA genes, which as noted above are significantly associated with a hypermucoviscosity phenotype, are located on a 180-kilobase plasmid [<a href="#rid30">30</a>]. This is consistent with the finding in a review of 241 blood isolates of <em>K. pneumoniae</em> that all 15 isolates (6 percent) producing aerobactin were associated with the hypermucoviscosity phenotype [<a href="#rid69">69</a>]. However, 20 percent of the isolates had a hypermucoviscosity phenotype. Thus, although the aerobactin gene was always associated with the rmpA gene, the rmpA gene was not always associated with the aerobactin gene indicating that some rmpA-encoding plasmids do not contain the aerobactin gene.</p><p>These observations suggest that the association of aerobactin with virulence could be mediated at least in part by the concurrent presence of the mucoid phenotype. This issue was addressed in knockout experiments in a K2 serotype <em>K. pneumoniae</em> strain [<a href="#rid30">30</a>]. RmpA-negative mutants were 1000 times less virulent than wild-type strains but still 100 times more virulent than the plasmid-less rmpA-negative and aerobactin-negative strains.</p><p>The latter observation supports a direct role for aerobactin-mediated iron uptake in virulence in the minority of <em>K. pneumoniae</em> strains that produce aerobactin. Further support for the role of iron uptake in virulence in <em>K. pneumoniae</em> comes from a study in which the kfu iron uptake system was associated with liver abscess formation and distant metastatic infection such as endophthalmitis [<a href="#rid52">52</a>]. In the series of 177 cases of <em>K. pneumoniae</em> liver abscess cited above, kfu was found in 97 percent of K1 strains but in no K2 strains, which may contribute to metastatic infection (eg, endophthalmitis) being relatively rare with K2 strains [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Pili (fimbriae)</span><span class="headingEndMark"> — </span>Strains of <em>K. pneumoniae</em> express two morphologically and functionally distinct filaments: type 1 and the type 3 pili [<a href="#rid70">70</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Type 1 pili are heteropolymeric mannose-binding fibers produced by all members of the Enterobacteriaceae family, which mediate adherence to many types of epithelial cells like the bladder epithelium [<a href="#rid71">71</a>]. In a review of 151 <em>K. pneumoniae</em> blood isolates, the type 1 fimbrial adhesion gene (fimH) was present in all but three (98 percent) [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The type 3 fimbrial adhesion protein (MrkD adhesin) plays a central role in the virulence of <em>K. pneumoniae</em> by attaching to host cells, such as of the urogenital, respiratory, and intestinal tracts [<a href="#rid72">72</a>]. This can result in bacterial colonization, subsequent proliferation on the host mucosal surfaces, and clinical infection such as pyelonephritis or pneumonia. Type 3 pili are also required for biofilm formation by <em>K. pneumoniae</em> on plastics and human extracellular matrix, leading to the formation of treatment-resistant biofilm on indwelling plastic devices, such as intravenous and urinary catheters [<a href="#rid73">73,74</a>].</p><p></p><p>These effects of pili may be counteracted by host responses. As an example, binding of the bacteria to the mucus or epithelial cells of the host may trigger lectinophagocytosis by macrophages, leading to intracellular killing of the bacteria [<a href="#rid13">13,14</a>]. Subsequent invasion of the bacteria into the underlying tissue or the bloodstream may also be hampered by complement-mediated serum killing. Thus, survival and growth of pathogenic bacteria requires the other virulence factors described above.</p><p class="headingAnchor" id="H13"><span class="h2">Virulence of ESBL-producing strains</span><span class="headingEndMark"> — </span>Dissemination or outbreak of extended-spectrum beta-lactamase (ESBL)-producing <em>K. pneumoniae</em> strains has been reported worldwide. (See  <a class="medical medical_review" href="/d/html/3122.html" rel="external">"Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection"</a>.)</p><p>As noted in the preceding section, fimbriae contribute to the virulence of <em>K. pneumoniae</em>. A specific fimbria, called KPF-28, has been found in the great majority of ESBL-producing <em>K. pneumoniae</em>, and the plasmid encoding the ESBL enzyme is involved in KPF-28 expression [<a href="#rid75">75</a>]. KPF-28 promotes adherence and bowel colonization of ESBL-producing <em>K. pneumoniae</em>, enhancing the likelihood of spread and nosocomial outbreaks.</p><p>Except for fimbriae, ESBL-producing <em>K. pneumoniae</em> have a low prevalence of the other <em>Klebsiella</em> virulence factors described above, including the hypermucoviscosity phenotype and aerobactin. This was illustrated in a report of 190 ESBL-producing <em>K. pneumoniae</em> clinical isolates from France: only 7 percent had a hypermucoviscosity phenotype, 4 percent produced aerobactin, and 2 percent had both factors [<a href="#rid76">76</a>]. Additionally, in a study from Taiwan, ESBL-producing <em>K. pneumoniae</em> strains had a lower carriage rate of rmpA gene, but had higher tendency of mutation in rmpA gene, thus resulting in lower prevalence of the hypermucoviscosity phenotype and less virulence of the isolates [<a href="#rid35">35</a>]. A study in China reported that low rmpA expression levels correlated with the absence of the hypervirulent phenotype in the rmpA-positive <em>K. pneumoniae</em> isolates [<a href="#rid77">77</a>]. (See <a class="local">'RmpA gene'</a> above.)</p><p>The low rate of these virulence factors suggests that ESBL-producing <em>K. pneumoniae</em> might have reduced virulence. The data have been conflicting in other studies as illustrated by the following observations:</p><p class="bulletIndent1"><span class="glyph">●</span>Support for reduced virulence comes from two studies from Taiwan in which ESBL-producing <em>K. pneumoniae</em> were not associated with invasive primary liver abscess [<a href="#rid78">78,79</a>]. The infections were primarily nosocomial [<a href="#rid78">78</a>], which rarely cause tissue abscesses due at least in part to a much lower prevalence of the hypermucoviscosity phenotype (15 versus 49 percent with community-acquired isolates in one report) [<a href="#rid22">22</a>]. (See <a class="local">'Association with primary liver abscess'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a review from five European countries, ESBL-producing <em>K. pneumoniae</em> strains had a significantly higher rate of resistance to the bactericidal effect of serum than non-ESBL-producing strains (30 versus 18 percent) [<a href="#rid80">80</a>]. In a second analysis from the same group, the ESBL-producing strains had a higher rate of capsular serotype K2; serotype K1 was rare [<a href="#rid17">17</a>]. After exclusion of the K1/K2 isolates which, as noted above, are associated with the hypermucoviscosity phenotype, the rate of serum resistance was similar in the ESBL- and non-ESBL-producing strains (about 12 percent).</p><p></p><p class="bulletIndent1">The cause of serum resistance in these isolates is not well understood since the hypermucoviscosity phenotype and aerobactin are uncommon in Europe [<a href="#rid76">76</a>], a linkage to the lipopolysaccharide O1 serotype is unclear [<a href="#rid80">80</a>], and the ESBL-encoding plasmid was not involved [<a href="#rid80">80</a>]. (See <a class="local">'Hypermucoviscosity phenotype'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>However, in a study from Taiwan, among non-K1/K2 <em>K. pneumoniae</em> strains, the trend towards more frequent serum resistance among ESBL-producing strains compared with non-ESBL strains was not statistically significant [<a href="#rid81">81</a>].</p><p></p><p>ESBL production has emerged among hypervirulent <em>K. pneumoniae</em> strains in China and Saudi Arabia [<a href="#rid3">3,82,83</a>]. In one study from Taiwan, hypervirulent ESBL-producing isolates (those with hypermucoviscosity phenotype, rmpA and rmpA2 genes) were more commonly recovered from diabetic patients and were mainly associated with bacteremia secondary to such infections as pneumonia and urinary tract infections [<a href="#rid84">84</a>]. Hypervirulent isolates have also been associated with health care-associated infections in Saudi Arabia, including patients in intensive care units; hospital-acquired hvKP isolates were associated with antimicrobial resistance and virulence factors such as K1, K2, rmpA, and rmpA2 [<a href="#rid3">3</a>]. Nonhypervirulent isolates were more commonly recovered from patients after prolonged hospital stays (&gt;30 days) and were mainly associated with primary bacteremia. The overall in-hospital mortality was 56.3 percent. </p><p><em>K. pneumoniae</em> carbapenemase-producing <em>K. pneumoniae</em> isolates exhibiting hypermucoviscosity phenotype, some of which carry rmpA and rmpA2 genes, have been identified in China, Brazil, the United States, and Taiwan [<a href="#rid85">85-88</a>]. Carbapenem-resistant and hypervirulent <em>K. pneumoniae</em> strains have become a great concern in China, although they remain rare in other parts of the world [<a href="#rid89">89</a>].</p><p class="headingAnchor" id="H43831948"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – <em>Klebsiella pneumoniae</em> is a gram-negative, lactose-fermenting, nonmotile, aerobic rod-shaped bacterium. There are three subspecies differentiated by distinct biochemical reactions: <em>K. pneumonia</em> subspecies <em>pneumoniae</em>, <em>ozaenae</em>, and <em>rhinoscleromatis</em>. (See <a class="local">'Introduction'</a> above and <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Virulence factors</strong> – Five major virulence factors of <em>K. pneumoniae</em> are known to contribute to the pathogenesis of infection. These are the capsular serotype, hypermucoviscosity phenotype, lipopolysaccharide, siderophores, and pili (<a class="graphic graphic_table graphicRef79361" href="/d/graphic/79361.html" rel="external">table 1</a>). (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Capsular serotype</strong> – Isolates with K1 and K2 capsular serotypes are generally more virulent than non-K1/K2 isolates of <em>K. pneumoniae</em>. (See <a class="local">'Capsular serotypes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hypermucoviscosity</strong> – The hypermucoviscosity phenotype is characterized by the ability to produce a mucoviscous exopolysaccharide web in sticky colonies on agar plates. These strains are associated with destructive tissue abscesses, including liver abscesses. (See <a class="local">'Hypermucoviscosity phenotype'</a> above and  <a class="medical medical_review" href="/d/html/3124.html" rel="external">"Invasive liver abscess syndrome caused by Klebsiella pneumoniae"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lipopolysaccharide</strong> – The lipopolysaccharide O side chain can impede complement binding to the <em>K. pneumoniae</em> cell membrane and thus protect the organism from complement-mediated membrane damage and cell death. (See <a class="local">'Lipopolysaccharide'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Siderophores</strong> – <em>K. pneumoniae</em> has developed multiple mechanisms to enhance iron uptake, including the synthesis of iron chelators, or siderophores. One of these, aerobactin, is associated with high virulence in mouse virulence assays. (See <a class="local">'Siderophores'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pili</strong> – Pili, or fimbriae, mediate adherence of <em>K. pneumoniae</em> to host cells, including those of the urogenital, respiratory, and intestinal tracts, but their effects may be counteracted by host responses. (See <a class="local">'Pili (fimbriae)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ESBL-producing isolates</strong> – A specific fimbria, called KPF-28, which promotes adherence and bowel colonization, has been found in the great majority of extended-spectrum beta-lactamase-producing <em>K. pneumoniae</em>. Otherwise, these resistant strains generally have a low prevalence of the other <em>K. pneumoniae</em> virulence factors. (See <a class="local">'Virulence of ESBL-producing strains'</a> above.)</p><p></p><p class="headingAnchor" id="H2480030086"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Yin-Ching Chuang, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589.</a></li><li><a class="nounderline abstract_t">Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev 2019; 32.</a></li><li><a class="nounderline abstract_t">Alharbi MT, Almuhayawi MS, Nagshabandi MK, et al. Antimicrobial Resistance Pattern, Pathogenicity and Molecular Properties of Hypervirulent Klebsiella pneumonia (hvKp) among Hospital-Acquired Infections in the Intensive Care Unit (ICU). Microorganisms 2023; 11.</a></li><li><a class="nounderline abstract_t">Cryz SJ Jr, Mortimer PM, Mansfield V, Germanier R. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 1986; 23:687.</a></li><li><a class="nounderline abstract_t">Fung CP, Hu BS, Chang FY, et al. A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis 2000; 181:2075.</a></li><li><a class="nounderline abstract_t">Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 2002; 50:420.</a></li><li><a class="nounderline abstract_t">Yeh KM, Kurup A, Siu LK, et al. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 2007; 45:466.</a></li><li><a class="nounderline abstract_t">Fang CT, Lai SY, Yi WC, et al. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 2007; 45:284.</a></li><li><a class="nounderline abstract_t">Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 2007; 54:578.</a></li><li><a class="nounderline abstract_t">Jenney AW, Clements A, Farn JL, et al. Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. J Clin Microbiol 2006; 44:102.</a></li><li><a class="nounderline abstract_t">Blanchette EA, Rubin SJ. Seroepidemiology of clinical isolates of Klebsiella in Connecticut. J Clin Microbiol 1980; 11:474.</a></li><li><a class="nounderline abstract_t">Mizuta K, Ohta M, Mori M, et al. Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infect Immun 1983; 40:56.</a></li><li><a class="nounderline abstract_t">Athamna A, Ofek I, Keisari Y, et al. Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun 1991; 59:1673.</a></li><li><a class="nounderline abstract_t">Ofek I, Goldhar J, Keisari Y, Sharon N. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 1995; 49:239.</a></li><li><a class="nounderline abstract_t">Kabha K, Nissimov L, Athamna A, et al. Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect Immun 1995; 63:847.</a></li><li><a class="nounderline abstract_t">Lin JC, Chang FY, Fung CP, et al. High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes Infect 2004; 6:1191.</a></li><li><a class="nounderline abstract_t">Sahly H, Aucken H, Benedi VJ, et al. Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 2004; 23:20.</a></li><li><a class="nounderline abstract_t">Cortés G, Borrell N, de Astorza B, et al. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 2002; 70:2583.</a></li><li><a class="nounderline abstract_t">Kawai T. Hypermucoviscosity: an extremely sticky phenotype of Klebsiella pneumoniae associated with emerging destructive tissue abscess syndrome. Clin Infect Dis 2006; 42:1359.</a></li><li><a class="nounderline abstract_t">Fang CT, Chuang YP, Shun CT, et al. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 2004; 199:697.</a></li><li><a class="nounderline abstract_t">Alvarez D, Merino S, Tomás JM, et al. Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates. Infect Immun 2000; 68:953.</a></li><li><a class="nounderline abstract_t">Yu WL, Ko WC, Cheng KC, et al. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis 2006; 42:1351.</a></li><li><a class="nounderline abstract_t">Lee HC, Chuang YC, Yu WL, et al. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med 2006; 259:606.</a></li><li><a class="nounderline abstract_t">Nadasy KA, Domiati-Saad R, Tribble MA. Invasive Klebsiella pneumoniae syndrome in North America. Clin Infect Dis 2007; 45:e25.</a></li><li><a class="nounderline abstract_t">Liao PY, Chiang WC, Chen SY, et al. Rapidly fatal gas-forming pyogenic psoas abscess caused by Klebsiella pneumoniae. Clin Infect Dis 2007; 44:1253.</a></li><li><a class="nounderline abstract_t">Ku YH, Chuang YC, Yu WL. Clinical spectrum and molecular characteristics of Klebsiella pneumoniae causing community-acquired extrahepatic abscess. J Microbiol Immunol Infect 2008; 41:311.</a></li><li><a class="nounderline abstract_t">Amako K, Meno Y, Takade A. Fine structures of the capsules of Klebsiella pneumoniae and Escherichia coli K1. J Bacteriol 1988; 170:4960.</a></li><li><a class="nounderline abstract_t">Nassif X, Honoré N, Vasselon T, et al. Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae. Mol Microbiol 1989; 3:1349.</a></li><li><a class="nounderline abstract_t">Arakawa Y, Ohta M, Wacharotayankun R, et al. Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2). Infect Immun 1991; 59:2043.</a></li><li><a class="nounderline abstract_t">Nassif X, Fournier JM, Arondel J, Sansonetti PJ. Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun 1989; 57:546.</a></li><li><a class="nounderline abstract_t">Wacharotayankun R, Arakawa Y, Ohta M, et al. Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect Immun 1993; 61:3164.</a></li><li><a class="nounderline abstract_t">Lai YC, Peng HL, Chang HY. RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level. J Bacteriol 2003; 185:788.</a></li><li><a class="nounderline abstract_t">van der Geest R, Fan H, Peñaloza HF, et al. Phagocytosis is a primary determinant of pulmonary clearance of clinical Klebsiella pneumoniae isolates. Front Cell Infect Microbiol 2023; 13:1150658.</a></li><li><a class="nounderline abstract_t">Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives. J Intern Med 2020; 287:283.</a></li><li><a class="nounderline abstract_t">Yu WL, Lee MF, Tang HJ, et al. Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing Klebsiella pneumoniae isolates. Virulence 2015; 6:162.</a></li><li><a class="nounderline abstract_t">Struve C, Bojer M, Nielsen EM, et al. Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1. J Med Microbiol 2005; 54:1111.</a></li><li><a class="nounderline abstract_t">Yeh KM, Chang FY, Fung CP, et al. magA is not a specific virulence gene for Klebsiella pneumoniae strains causing liver abscess but is part of the capsular polysaccharide gene cluster of K. pneumoniae serotype K1. J Med Microbiol 2006; 55:803.</a></li><li><a class="nounderline abstract_t">Yeh KM, Chang FY, Fung CP, et al. Serotype K1 capsule, rather than magA per se, is really the virulence factor in Klebsiella pneumoniae strains that cause primary pyogenic liver abscess. J Infect Dis 2006; 194:403.</a></li><li><a class="nounderline abstract_t">Chuang YP, Fang CT, Lai SY, et al. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 2006; 193:645.</a></li><li><a class="nounderline abstract_t">Yu WL, Fung CP, Ko WC, et al. Polymerase chain reaction analysis for detecting capsule serotypes K1 and K2 of Klebsiella pneumoniae causing abscesses of the liver and other sites. J Infect Dis 2007; 195:1235.</a></li><li><a class="nounderline abstract_t">Turton JF, Englender H, Gabriel SN, et al. Genetically similar isolates of Klebsiella pneumoniae serotype K1 causing liver abscesses in three continents. J Med Microbiol 2007; 56:593.</a></li><li><a class="nounderline abstract_t">Yeh KM, Lin JC, Yin FY, et al. Revisiting the importance of virulence determinant magA and its surrounding genes in Klebsiella pneumoniae causing pyogenic liver abscesses: exact role in serotype K1 capsule formation. J Infect Dis 2010; 201:1259.</a></li><li><a class="nounderline abstract_t">Fang CT, Lai SY, Yi WC, et al. The function of wzy_K1 (magA), the serotype K1 polymerase gene in Klebsiella pneumoniae cps gene cluster. J Infect Dis 2010; 201:1268.</a></li><li><a class="nounderline abstract_t">Pan YJ, Fang HC, Yang HC, et al. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol 2008; 46:2231.</a></li><li><a class="nounderline abstract_t">Hsu CR, Lin TL, Chen YC, et al. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology 2011; 157:3446.</a></li><li><a class="nounderline abstract_t">Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8:160.</a></li><li><a class="nounderline abstract_t">Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 2002; 162:1021.</a></li><li><a class="nounderline abstract_t">Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 1998; 26:1434.</a></li><li><a class="nounderline abstract_t">Yang CC, Yen CH, Ho MW, Wang JH. Comparison of pyogenic liver abscess caused by non-Klebsiella pneumoniae and Klebsiella pneumoniae. J Microbiol Immunol Infect 2004; 37:176.</a></li><li><a class="nounderline abstract_t">Cheng DL, Liu YC, Yen MY, et al. Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med 1991; 151:1557.</a></li><li><a class="nounderline abstract_t">Yang CC, Chen CY, Lin XZ, et al. Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol 1993; 88:1911.</a></li><li><a class="nounderline abstract_t">Ma LC, Fang CT, Lee CZ, et al. Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis 2005; 192:117.</a></li><li><a class="nounderline abstract_t">Yu WL, Ko WC, Cheng KC, et al. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 2008; 62:1.</a></li><li><a class="nounderline abstract_t">Hu D, Chen W, Wang W, et al. Hypercapsule is the cornerstone of Klebsiella pneumoniae in inducing pyogenic liver abscess. Front Cell Infect Microbiol 2023; 13:1147855.</a></li><li><a class="nounderline abstract_t">Lin JC, Siu LK, Fung CP, et al. Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab 2006; 91:3084.</a></li><li><a class="nounderline abstract_t">Yu WL, Chan KS, Ko WC, et al. Lower prevalence of diabetes mellitus in patients with Klebsiella pneumoniae primary liver abscess caused by isolates of K1/K2 than with non-K1/K2 capsular serotypes. Clin Infect Dis 2007; 45:1529.</a></li><li><a class="nounderline abstract_t">Tomás JM, Benedí VJ, Ciurana B, Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 1986; 54:85.</a></li><li><a class="nounderline abstract_t">McCallum KL, Laakso DH, Whitfield C. Use of a bacteriophage-encoded glycanase enzyme in the generation of lipopolysaccharide O side chain deficient mutants of Escherichia coli O9:K30 and Klebsiella O1:K20: role of O and K antigens in resistance to complement-mediated serum killing. Can J Microbiol 1989; 35:994.</a></li><li><a class="nounderline abstract_t">Albertí S, Marqués G, Camprubí S, et al. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun 1993; 61:852.</a></li><li><a class="nounderline abstract_t">Albertí S, Alvarez D, Merino S, et al. Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae. Infect Immun 1996; 64:4726.</a></li><li><a class="nounderline abstract_t">Shankar-Sinha S, Valencia GA, Janes BK, et al. The Klebsiella pneumoniae O antigen contributes to bacteremia and lethality during murine pneumonia. Infect Immun 2004; 72:1423.</a></li><li><a class="nounderline abstract_t">Miles AA, Khimji PL. Enterobacterial chelators of iron: their occurrence, detection, and relation to pathogenicity. J Med Microbiol 1975; 8:477.</a></li><li><a class="nounderline abstract_t">Lodge JM, Williams P, Brown MR. Influence of growth rate and iron limitation on the expression of outer membrane proteins and enterobactin by Klebsiella pneumoniae grown in continuous culture. J Bacteriol 1986; 165:353.</a></li><li><a class="nounderline abstract_t">Nassif X, Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun 1986; 54:603.</a></li><li><a class="nounderline abstract_t">Williams P, Smith MA, Stevenson P, et al. Novel aerobactin receptor in Klebsiella pneumoniae. J Gen Microbiol 1989; 135:3173.</a></li><li><a class="nounderline abstract_t">Podschun R, Sievers D, Fischer A, Ullmann U. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis 1993; 168:1415.</a></li><li><a class="nounderline abstract_t">Podschun R, Fischer A, Ullmann U. Siderophore production of Klebsiella species isolated from different sources. Zentralbl Bakteriol 1992; 276:481.</a></li><li><a class="nounderline abstract_t">Tarkkanen AM, Allen BL, Williams PH, et al. Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun 1992; 60:1187.</a></li><li><a class="nounderline abstract_t">Vernet V, Philippon A, Madoulet C, et al. Virulence factors (aerobactin and mucoid phenotype) in Klebsiella pneumoniae and Escherichia coli blood culture isolates. FEMS Microbiol Lett 1995; 130:51.</a></li><li><a class="nounderline abstract_t">Gerlach GF, Clegg S, Allen BL. Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol 1989; 171:1262.</a></li><li><a class="nounderline abstract_t">Jones CH, Pinkner JS, Roth R, et al. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A 1995; 92:2081.</a></li><li><a class="nounderline abstract_t">Sebghati TA, Korhonen TK, Hornick DB, Clegg S. Characterization of the type 3 fimbrial adhesins of Klebsiella strains. Infect Immun 1998; 66:2887.</a></li><li><a class="nounderline abstract_t">Jagnow J, Clegg S. Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces. Microbiology 2003; 149:2397.</a></li><li><a class="nounderline abstract_t">Langstraat J, Bohse M, Clegg S. Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbrial adhesin (MrkD), facilitates biofilm formation. Infect Immun 2001; 69:5805.</a></li><li><a class="nounderline abstract_t">Di Martino P, Livrelli V, Sirot D, et al. A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 1996; 64:2266.</a></li><li><a class="nounderline abstract_t">Vernet V, Madoulet C, Chippaux C, Philippon A. Incidence of two virulence factors (aerobactin and mucoid phenotype) among 190 clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamase. FEMS Microbiol Lett 1992; 75:1.</a></li><li><a class="nounderline abstract_t">Lin ZW, Zheng JX, Bai B, et al. Characteristics of Hypervirulent Klebsiella pneumoniae: Does Low Expression of rmpA Contribute to the Absence of Hypervirulence? Front Microbiol 2020; 11:436.</a></li><li><a class="nounderline abstract_t">Lin TL, Tang SI, Fang CT, et al. Extended-spectrum beta-lactamase genes of Klebsiella pneumoniae strains in Taiwan: recharacterization of shv-27, shv-41, and tem-116. Microb Drug Resist 2006; 12:12.</a></li><li><a class="nounderline abstract_t">Chan KS, Yu WL, Tsai CL, et al. Pyogenic liver abscess caused by Klebsiella pneumoniae: analysis of the clinical characteristics and outcomes of 84 patients. Chin Med J (Engl) 2007; 120:136.</a></li><li><a class="nounderline abstract_t">Sahly H, Aucken H, Benedí VJ, et al. Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2004; 48:3477.</a></li><li><a class="nounderline abstract_t">Lin HA, Huang YL, Yeh KM, et al. Regulator of the mucoid phenotype A gene increases the virulent ability of extended-spectrum beta-lactamase-producing serotype non-K1/K2 Klebsiella pneumonia. J Microbiol Immunol Infect 2016; 49:494.</a></li><li><a class="nounderline abstract_t">Liu YM, Li BB, Zhang YY, et al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother 2014; 58:5379.</a></li><li><a class="nounderline abstract_t">Li W, Sun G, Yu Y, et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin Infect Dis 2014; 58:225.</a></li><li><a class="nounderline abstract_t">Yu WL, Lee MF, Chen CC, et al. Impacts of Hypervirulence Determinants on Clinical Features and Outcomes of Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae. Microb Drug Resist 2017; 23:376.</a></li><li><a class="nounderline abstract_t">Dong N, Lin D, Zhang R, et al. Carriage of blaKPC-2 by a virulence plasmid in hypervirulent Klebsiella pneumoniae. J Antimicrob Chemother 2018; 73:3317.</a></li><li><a class="nounderline abstract_t">Araújo BF, Ferreira ML, Campos PA, et al. Hypervirulence and biofilm production in KPC-2-producing Klebsiella pneumoniae CG258 isolated in Brazil. J Med Microbiol 2018; 67:523.</a></li><li><a class="nounderline abstract_t">Wozniak JE, Band VI, Conley AB, et al. A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance. Antimicrob Agents Chemother 2019; 63.</a></li><li><a class="nounderline abstract_t">Huang YH, Chou SH, Liang SW, et al. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan. J Antimicrob Chemother 2018; 73:2039.</a></li><li><a class="nounderline abstract_t">Yu F, Lv J, Niu S, et al. Multiplex PCR Analysis for Rapid Detection of Klebsiella pneumoniae Carbapenem-Resistant (Sequence Type 258 [ST258] and ST11) and Hypervirulent (ST23, ST65, ST86, and ST375) Strains. J Clin Microbiol 2018; 56.</a></li></ol></div><div id="topicVersionRevision">Topic 3125 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9767057" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31092506" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Hypervirulent Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36985234" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Antimicrobial Resistance Pattern, Pathogenicity and Molecular Properties of Hypervirulent Klebsiella pneumonia (hvKp) among Hospital-Acquired Infections in the Intensive Care Unit (ICU).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3517058" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10837197" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11839725" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17151209" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17599305" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17175028" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16390956" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7381012" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Seroepidemiology of clinical isolates of Klebsiella in Connecticut.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6187694" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2019437" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8561460" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Nonopsonic phagocytosis of microorganisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7868255" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15488738" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14652783" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11953399" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16619145" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hypermucoviscosity: an extremely sticky phenotype of Klebsiella pneumoniae associated with emerging destructive tissue abscess syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14993253" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10639470" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16619144" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16704562" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17599300" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Invasive Klebsiella pneumoniae syndrome in North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17407050" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Rapidly fatal gas-forming pyogenic psoas abscess caused by Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18787738" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clinical spectrum and molecular characteristics of Klebsiella pneumoniae causing community-acquired extrahepatic abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3049556" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Fine structures of the capsules of Klebsiella pneumoniae and Escherichia coli K1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2693894" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2037364" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2643575" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8335346" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12533454" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37056705" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Phagocytosis is a primary determinant of pulmonary clearance of clinical Klebsiella pneumoniae isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31677303" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25830726" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrumβ-lactamase-producing Klebsiella pneumoniae isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16192445" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16687604" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : magA is not a specific virulence gene for Klebsiella pneumoniae strains causing liver abscess but is part of the capsular polysaccharide gene cluster of K. pneumoniae serotype K1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16826492" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Serotype K1 capsule, rather than magA per se, is really the virulence factor in Klebsiella pneumoniae strains that cause primary pyogenic liver abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16453259" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17357063" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Polymerase chain reaction analysis for detecting capsule serotypes K1 and K2 of Klebsiella pneumoniae causing abscesses of the liver and other sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17446279" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Genetically similar isolates of Klebsiella pneumoniae serotype K1 causing liver abscesses in three continents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19785524" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Revisiting the importance of virulence determinant magA and its surrounding genes in Klebsiella pneumoniae causing pyogenic liver abscesses: exact role in serotype K1 capsule formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20225957" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The function of wzy_K1 (magA), the serotype K1 polymerase gene in Klebsiella pneumoniae cps gene cluster.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18508935" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21964731" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11897067" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11996612" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9636876" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Primary liver abscess due to Klebsiella pneumoniae in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15221038" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Comparison of pyogenic liver abscess caused by non-Klebsiella pneumoniae and Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1872659" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8237941" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15942901" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18486404" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37065211" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Hypercapsule is the cornerstone of Klebsiella pneumoniae in inducing pyogenic liver abscess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16720670" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17990242" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Lower prevalence of diabetes mellitus in patients with Klebsiella pneumoniae primary liver abscess caused by isolates of K1/K2 than with non-K1/K2 capsular serotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3531020" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2482125" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Use of a bacteriophage-encoded glycanase enzyme in the generation of lipopolysaccharide O side chain deficient mutants of Escherichia coli O9:K30 and Klebsiella O1:K20: role of O and K antigens in resistance to complement-mediated serum killing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8432605" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8890232" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14977947" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The Klebsiella pneumoniae O antigen contributes to bacteremia and lethality during murine pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/812996" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Enterobacterial chelators of iron: their occurrence, detection, and relation to pathogenicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2935522" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Influence of growth rate and iron limitation on the expression of outer membrane proteins and enterobactin by Klebsiella pneumoniae grown in continuous culture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2946641" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2534599" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Novel aerobactin receptor in Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7902383" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1535249" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Siderophore production of Klebsiella species isolated from different sources.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1347287" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7557296" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Virulence factors (aerobactin and mucoid phenotype) in Klebsiella pneumoniae and Escherichia coli blood culture isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2563996" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7892228" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9596764" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Characterization of the type 3 fimbrial adhesins of Klebsiella strains.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12949165" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11500458" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbrial adhesin (MrkD), facilitates biofilm formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8675336" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1388129" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Incidence of two virulence factors (aerobactin and mucoid phenotype) among 190 clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32256482" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Characteristics of Hypervirulent Klebsiella pneumoniae: Does Low Expression of rmpA Contribute to the Absence of Hypervirulence?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16584302" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Extended-spectrum beta-lactamase genes of Klebsiella pneumoniae strains in Taiwan: recharacterization of shv-27, shv-41, and tem-116.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17335656" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Pyogenic liver abscess caused by Klebsiella pneumoniae: analysis of the clinical characteristics and outcomes of 84 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15328114" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25442871" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Regulator of the mucoid phenotype A gene increases the virulent ability of extended-spectrum beta-lactamase-producing serotype non-K1/K2 Klebsiella pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24982067" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24099919" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27380450" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Impacts of Hypervirulence Determinants on Clinical Features and Outcomes of Bacteremia Caused by Extended-Spectrumβ-Lactamase-Producing Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30239821" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Carriage of blaKPC-2 by a virulence plasmid in hypervirulent Klebsiella pneumoniae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29509136" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Hypervirulence and biofilm production in KPC-2-producing Klebsiella pneumoniae CG258 isolated in Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30803966" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29800340" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29925644" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Multiplex PCR Analysis for Rapid Detection of Klebsiella pneumoniae Carbapenem-Resistant (Sequence Type 258 [ST258] and ST11) and Hypervirulent (ST23, ST65, ST86, and ST375) Strains.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
